Vinge has advised Pareto Securities in its capacity as Sole Manager and Bookrunner on the deal. Baker McKenzie advised Xbrane Biopharma. Xbrane Biopharma AB successfully carried…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Paolo Bossi
…
This content is for Standard 1 Year members only. LoginJoin Now